A carregar...

Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists

Antagonists of peripheral type 1 cannabinoid receptors (CB1) may have utility in the treatment of obesity, liver disease, metabolic syndrome and dyslipidemias. We have targeted the purine otenabant (1) analogues for this purpose. The non-tissue selective CB1 antagonist rimonabant (2) was approved as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bioorg Med Chem
Main Authors: Amato, George S., Manke, Amruta, Vasukuttan, Vineetha, Wiethe, Robert W., Snyder, Rodney W., Runyon, Scott P., Maitra, Rangan
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6129194/
https://ncbi.nlm.nih.gov/pubmed/30077609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2018.07.043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!